Genomic footprints of activated telomere maintenance mechanisms in cancer
Lina SieverlingiD, Chen HongiD, Sandra D. Koser, Philip Ginsbach, Kortine KleinheinziD, Barbara HutteriD, Delia M. BrauniD, Isidro Cortés‐CirianoiD, Ruibin XiiD, Rolf KabbeiD, Peter J. ParkiD, Roland EilsiD, Matthias SchlesneriD, PCAWG-Structural Variation Working Group, Kadir C. Akdemir, Eva G. Alvarez, Adrian Baez-Ortega, Rameen BeroukhimiD, Paul C. BoutrosiD, David D.L. BowtelliD, Benedikt BrorsiD, Kathleen H. BurnsiD, Peter J. CampbelliD, Kin ChaniD, Ken CheniD, , Rehan AkbaniiD
Abstract
Cancers require telomere maintenance mechanisms for unlimited replicative potential. We dissected whole-genome sequencing data of over 2,500 matched tumor-control samples from 36 different tumor types to characterize the genomic footprints of these mechanisms. While the telomere content of tumors with ATRX or DAXX mutations (ATRX/DAXXtrunc) was increased, tumors with TERT modifications showed a moderate decrease of telomere content. One quarter of all tumor samples contained somatic integrations of telomeric sequences into non-telomeric DNA. With 80% prevalence, ATRX/DAXXtrunc tumors display a 3-fold enrichment of telomere insertions. A systematic analysis of telomere composition identified aberrant telomere variant repeat (TVR) distribution as a genomic marker of ATRX/DAXXtrunc tumors. In this clinically relevant subgroup, singleton TTCGGG and TTTGGG TVRs (previously undescribed) were significantly enriched or depleted, respectively. Overall, our findings provide new insight into the recurrent genomic alterations that are associated with the establishment of different telomere maintenance mechanisms in cancer.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 133
- FWCI
- 12.77
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alternative Lengthening of Telomeres is not synonymous with mutations in ATRX/DAXX
A. de Nonneville, R. R. Reddel·bioRxiv·May 5, 2020
- Cancer-associated DAXX mutations reveal a critical role for ATRX localization in ALT suppression
Sarah F. Clatterbuck Soper, Robert L. Walker, … Paul S. Meltzer·Molecular and Cellular BiologyPeer-reviewed·Dec 21, 2025
- Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines
- Mapping the genomic and transcriptomic features associated with telomere maintenance mechanisms in complex karyotype sarcomas
Nicola Biondi, Maria Luisa Ratto, … Priya Chudasama·bioRxiv·May 26, 2026
- Loss of function of Atrx leads to activation of alternative lengthening of telomeres in a primary mouse model of sarcoma
M. Pierpoint, W. Floyd, … D. G. Kirsch·bioRxiv·Nov 6, 2023
- Neotelomere formation by human telomerase
C. G. Kinzig, G. Zakusilo, … T. de Lange·bioRxiv·Oct 31, 2022